Business Description

Description
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).

Financials (Next Earnings Date:2024-05-03 Est.)

LTS:0JDI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ionis Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 787.647
EPS (TTM) ($) -2.56
Beta -0.17
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 37.628
12-1 Month Momentum % 0
52-Week Range ($) 37.628 - 37.628
Shares Outstanding (Mil) 145.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ionis Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Ionis Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Ionis Pharmaceuticals Inc Frequently Asked Questions

What is Ionis Pharmaceuticals Inc(LTS:0JDI)'s stock price today?
The current price of LTS:0JDI is $37.63. The 52 week high of LTS:0JDI is $37.63 and 52 week low is $37.63.
When is next earnings date of Ionis Pharmaceuticals Inc(LTS:0JDI)?
The next earnings date of Ionis Pharmaceuticals Inc(LTS:0JDI) is 2024-05-03 Est..
Does Ionis Pharmaceuticals Inc(LTS:0JDI) pay dividends? If so, how much?
Ionis Pharmaceuticals Inc(LTS:0JDI) does not pay dividend.

Press Release

Subject Date
No Press Release